Life Line Screening and Bone Index, Ltd. To Bring State-of-the-Art Bone Density Screening to American Communities

AUSTIN, Texas–(BUSINESS WIRE)–#Bindex–Bone Index, Ltd., one of Europe’s top new manufacturers of medical
devices, and Life Line Screening, the US’s leading provider of direct to
consumer preventive health and wellness screenings, have joined forces
to bring cutting edge bone density screening to American consumers
through Life Line’s community-based screening events.

Undiagnosed osteoporosis is a worldwide challenge. In the US alone
osteoporosis is responsible for two million broken bones every year,
costing over 19 billion dollars. Experts forecast that by 2025, the
costs will rise to 25.3 billion dollars. One of the biggest challenges
is the limited availability of osteoporosis diagnostics since bone
density scans are mostly performed in hospitals with large DXA X-ray
machines that entail high costs. “This is why Bindex^® is
a game-changer,” says Bone Index’s CEO, Dr. Ossi Riekkinen

“Life Line Screening provides health and wellness services at
approximately 15,000 screening events throughout the United States,
including ultrasound screening for vascular disease and bone density.
Partnering with Bone Index, Ltd, allows us to bring more accurate and
convenient bone density screening to the public,” says Kelly Daubach,
VP, Business Development, Life Line Screening. “No other screening
company will have a more accurate, safe or simple test for Osteoporosis.”

Bindex^® point-of-care device measures the cortical bone
thickness of the tibia and the algorithm calculates the Density Index, a
parameter which estimates bone mineral density at the hip as measured
with DXA.

Bindex^® has a total of 19 patents globally including the US,
China, Japan and large European countries. “Now Bindex is used in the
world’s largest osteoporosis screening campaign in Finland, and we are
pleased to partner with Life Line Screening for providing Bindex in the
US. The overall aim is to prevent osteoporotic fractures and improve the
quality of life for families in the US,” Dr. Riekkinen concludes.

For more information:
Bone Index Ltd., Dr. Ossi Riekkinen,
CEO,
ossi.riekkinen@boneindex.fi
, +358 50 363 2797, www.bindex.fi/en/

Life Line Screening, Kelly Daubach, VP, Business Development
Kelly.Daubach@llsa.com,
407-734-4082

About Bone Index:

Founded in 2011 and based in Kuopio, Bone Index Finland Ltd. specializes
in the development of measuring devices for osteoporosis screening and
diagnosis.

About Life Line Screening

Life Line Screening is the nation’s leading provider of preventive
health and wellness screenings. Life Line’s teams deliver patient
specific preventive health care screenings locally to consumers
motivated to stay informed about their health. To learn more, visit www.lifelinescreening.com.

Contacts

Bone Index Ltd.
Dr. Ossi Riekkinen, CEO, +358 50 363 2797
ossi.riekkinen@boneindex.fi
www.bindex.fi/en/
or
Life
Line Screening
Kelly Daubach, VP, Business Development, 407-734-4082
Kelly.Daubach@llsa.com,